Cannara Biotech Taps Nicholas Fozard for CFO Role

Fozard brings a specialized background in public-company reporting, manufacturing finance, and capital markets to the Montreal-based firm. His appointment remains subject to the receipt of a mandatory Health Canada security clearance, a standard regulatory step for all officers and directors within the company.

Sosiak, who served as finance chief since 2020, has been managing the handover process since his promotion in April. The leadership shift aims to bolster Cannara’s financial oversight as the company navigates ongoing sector transactions and operational scaling.